The bill modifies the premium tax credit and introduces measures to prevent fraudulent insurance enrollment. It extends open enrollment, introduces new pharmacy benefit manager (PBM) requirements, and aims to increase transparency and oversight of PBMs to potentially lower drug costs. It also addresses rebates, fees, and remuneration for health plans and insurance coverage, including the ability for qualified Exchange enrollees to establish health savings accounts. The bill impacts the affordability of health insurance, prescription drug availability and cost, and health and insurance regulations. It allows eligible individuals to prepay their annual health insurance premiums and directs a portion of the premium tax credit into Health Savings Accounts.
